Jazz Pharmaceuticals plc buy Royal Bank of Canada
Start price
10.08.23
/
50%
€123.15
Target price
10.08.24
€182.37
Performance (%)
-21.61%
Price
29.05.24
€96.54
Summary
This prediction is currently active. The prediction for Jazz Pharmaceuticals plc disappoints with a performance of -21.61%. This prediction currently runs until 10.08.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | -0.964% | -0.964% |
| iShares Core DAX® | -0.683% | 1.890% |
| iShares Nasdaq 100 | 0.335% | 4.631% |
| iShares Nikkei 225® | -1.486% | -2.361% |
| iShares S&P 500 | -0.523% | 2.324% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its price target lowered by analysts at Royal Bank of Canada from $203.00 to $201.00. They now have an "outperform" rating on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€109.90
29.02.24
29.02.24
€180.57
28.02.25
28.02.25
-12.16%
29.05.24
29.05.24
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€110.15
09.11.23
09.11.23
€178.99
09.11.24
09.11.24
-13.10%
29.05.24
29.05.24